Expression of Epidermal c-Kit+ of Vitiligo Lesions Is Related to Responses to Excimer Laser
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The survival and growth of melanocytes are controlled by the binding of stem cell factor to its cell surface receptor c-kit+ (CD117). We have observed that c-kit+ melanocytes existed in some lesions of vitiligo, while Melan A+ cells were absent. Objective: To verify possible relation between c-kit+ expression and treatment response in non-segmental vitiligo lesions Methods: Skin biopsies were done from the center of the 47 lesions from the 47 patients with non-segmental vitiligo. Expression of c-kit+ and Melan A, and amounts of melanin in the epidermis were assessed in each lesion, and treatment responses to excimer laser were evaluated. Results: Thirty-five of the 47 lesions (74.5%) had c-kit+ phenotypes. There was significant difference of c-kit staining value between good responders in 3 months of excimer laser treatment (average of 24 sessions) and the others. Conclusion: c-Kit expression in vitiliginous epidermis may be related to better treatment responses to excimer laser.
Abstract
Background: The survival and growth of melanocytes are controlled by the binding of stem cell factor to its cell surface receptor c-kit+ (CD117). We have observed that c-kit+ melanocytes existed in some lesions of vitiligo, while Melan A+ cells were absent. Objective: To verify possible relation between c-kit+ expression and treatment response in non-segmental vitiligo lesions Methods: Skin biopsies were done from the center of the 47 lesions from the 47 patients with non-segmental vitiligo. Expression of c-kit+ and Melan A, and amounts of melanin in the epidermis were assessed in each lesion, and treatment responses to excimer laser were evaluated. Results: Thirty-five of the 47 lesions (74.5%) had c-kit+ phenotypes. There was significant difference of c-kit staining value between good responders in 3 months of excimer laser treatment (average of 24 sessions) and the others. Conclusion: c-Kit expression in vitiliginous epidermis may be related to better treatment responses to excimer laser.
참고문헌 (25)
- Bolognia J., "Dermatology" (2008), Mosby Elsevier
- Nicolaidou E., "Childhood-and later-onset vitiligo have diverse epidemiologic and clinical characteristics", J Am Acad Dermatol, 66, pp.954~958 (2012)
- Agarwal S., "Clinical predictors for the course of nonsegmental vitiligo", Clin Exp Dermatol, 38, pp.669~670 (2013)
- Singh ZN., "Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis : lessons learned from vitiligo", Mod Pathol, 19, pp.1255~1260 (2006)
- El-Shabrawi-Caelen L., "Hypopigmented mycosis fungoides : frequent expression of a CD8+ T-cell phenotype", Am J Surg Pathol, 26, pp.450~457 (2002)
- Steitz J., "Initiation and regulation of CD8+T cells recognizing melanocytic antigens in the epidermis : implications for the pathophysiology of vitiligo", Eur J Cell Biol, 83, pp.797~803 (2004)
- Mandelcorn-Monson RL., "Cytotoxic T lymphocyte reactivity to gp100, MelanA", MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients, 2003, pp.121, 550~556
- Kasamatsu S., "Production of the soluble form of KIT, s-KIT, abolishes stem cell factor-induced melanogenesis in human melanocytes", J Invest Dermatol, 128, pp.1763~1772 (2008)
- Richards KA., "A novel KIT mutation results in piebaldism with progressive depigmentation", J Am Acad Dermatol, 44, pp.288~292 (2001)
- 김지영, "Amelanotic Acral Melanoma Associated with KIT Mutation and Vitiligo", Annals of Dermatology, 27(2), pp.201~205 (2015), 대한피부과학회
- Aoki H., "Protective effect of Kit signaling for melanocyte stem cells against radiation-induced genotoxic stress", J Invest Dermatol, 131, pp.1906~1915 (2011)
- Do JE., "The effect of 308nm excimer laser on segmental vitiligo : a retrospective study of 80 patients with segmental vitiligo", Photodermatol Photoimmunol Photomed, 27, pp.147~151 (2011)
- Nicolaidou E., "Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo : a review", J Am Acad Dermatol, 60, pp.470~477 (2009)
- Roskoski R Jr, "Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor", Biochem Biophys Res Commun, 337, pp.1~13 (2005)
- Kitamura R., "Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis : role of SCF", KIT protein interactions and the downstream effector, MITF-M, 2004, pp.202, 463~475
- Mizutani Y., "A single UVB exposure increases the expression of functional KIT in human melanocytes by up-regulating MITF expression through the phosphorylation of p38", CREB, 2010, pp.302, 283~294
- Kawalek AZ., "Combined excimer laser and topical tacrolimus for the treatment of vitiligo : a pilot study", Dermatol Surg, 30, pp.130~135 (2004)
- and solar irradiation for vitiligo vulgaris : upregulation of c-Kit mRNA by cultured melanocytes, "Eur J Dermatol", 2003, 372~376
- Jeon S., "Stem cell factor induces ERM proteins phosphorylation through PI3K activation to mediate melanocyte proliferation and migration", Pigment Cell Melanoma Res, 22, pp.77~85 (2009)
- Lennartsson J., "Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor", c-kit mediated activation of the Ras, Oncogene, pp.1999, 18[DOI]
- Kaliyadan F., "Optimizing the efficacy of targeted phototherapy by marking early vitiligo lesions after visualizing under a Wood's lamp", J Am Acad Dermatol, 71, pp.e69~ (2014)
- Norris A., "The expression of the c-kit receptor by epidermal melanocytes may be reduced in vitiligo", Br J Dermatol, 134, pp.299~306 (1996)
- Tachibana M., "Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics", Nat Genet, 14, pp.50~54 (1996)
- Hemesath TJ., "MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes", Nature, 391, pp.298~301 (1998)
- van den Boorn JG., "Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients", J Invest Dermatol, 129, pp.2220~2232 (2009)